Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ganirelix in COS/IUI cycles after prior premature luteinization
ACTRN12612000153819Phase 4Completed
- Sponsor
- Mersin University
- Start
- Jun 2007
- Modality
- Small Molecules, Peptides
- Countries
- 1
01
Overview
Phase 4, open-label trial of ganirelix in infertility (2 arms), sponsored by Mersin University. Primary endpoints: Biochemical pregnancy, Clinical pregnancy and 1 more. Started Jun 2007; status: completed.
02
Drugs
ganirelix
03
Conditions
infertility
Beyond the preview
Go deeper on ACTRN12612000153819.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12612000153819.